Most Recent
Class action funder’s son drops appeal of ruling linking him to Banksia scam
The son of the lawyer behind the Banksia Securities class action has effectively abandoned his appeal of a court judgment that found he knowingly and actively assisted his father in a fraudulent scheme to pocket almost $20 million in inflated fees and commission.
Major firms dragged to court by clients, partners in 2022
Some of Australia's biggest law firms were targeted by lawsuits in 2022, facing allegations of negligence or bad advice from clients, or else accused by their own partners of misconduct.
ASIC brings action against Firstmac over alleged DDO breaches
In only the second case of its kind, ASIC has taken non-bank lender Firstmac to court over alleged breaches of design and distribution obligations in relation to its High Livez managed investment scheme.
ASIC brings first-ever financial penalty case for alleged claims handling breach
The Australian Securities and Investments Commission has brought proceedings against insurance company OnePath Life, marking the first time the corporate regulator is seeking financial penalties for an alleged failure to act with utmost good faith during claims handling.
Banksia judge faces possible recusal bid by companies linked to silk’s wife
The judge whose ruling against the legal team behind the Banksia class action fraud helped redeem the battered reputation of the civil justice system may be asked to disqualify himself from the final fight in the drawn out case.
Purdue unit sued over patent extension for opioid Targin
Australian pharmaceutical company AUPharma has sued the international arm of Purdue, alleging it was wrongly granted patent extensions for several oxycodone products marketed as Targin. 
Companies linked to Banksia class action fraudsters should pay up, court told
Dead or broke, the class action lawyers who schemed to defraud investors in failed Banksia Securities should not escape a $21 million judgment for damages and costs, a court has heard.
Novartis, Pharmacor resolve suit over Gilenya patents
Novartis and and generic drug maker Pharmacor have resolved litigation over the Swiss pharmaceutical giant's patents for blockbuster MS drug Gilenya.
Major win for Lendlease, Multiplex in $68M case by Hastie liquidators
Lendlease and other major builders have secured a significant victory in a long-running case brought by the liquidators of failed engineering company Hastie Group, with a judge saying Hastie wasn't entitled to the proceeds of bank guarantees withdrawn by the builders when it collapsed 10 years ago.
Judge holidaying with Maddocks CEO won’t recuse himself from law firm client’s case
A judge has rejected a bid for his recusal from a contractual dispute in which Maddocks is acting, despite his personal friendship and holiday plans with the law firm's CEO.